- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 9)-iFluor® 440 Succinimidyl Ester
Anti-C5 MAb (Clone 9)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5707)
This product is comprised of an Humanized Anti-C5 IgG1-kappa (Clone 9) labeled with iFluor® 440 Succinimidyl Ester. iFluor® 440 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG1-kappa (Clone 9)
- Species Reactivity
- Human
- Name
- iFluor® 440 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 434/480
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MST1R MAb (Clone 2)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14302)
- Anti-APP MAb (Clone 16)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8772)
- Anti-LAMP1 MAb (Clone 4)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6436)
- Anti-MET MAb (Clone 28)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16801)
- Anti-LAMP1 MAb (Clone 4)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS284)
- Anti-MET MAb (Clone 23)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16796)
- Anti-CD3E MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15553)
- Anti-EGFR MAb (Clone 18)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10072)
- Anti-CD2 MAb (Clone 11)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14950)
- Anti-HLA-DRB1 MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8963)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS5707. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-737 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-736 | Anti-C5 (Pexelizumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
